|
| Methanone, [4-(2-chloro-4-nitrophenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)- Basic information |
Product Name: | Methanone, [4-(2-chloro-4-nitrophenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)- | Synonyms: | Methanone, [4-(2-chloro-4-nitrophenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)-;Nucleozin;[4-(2-Chloro-4-nitro-phenyl)-piperazin-1-yl]-(5-methyl-3-phenyl-isoxazol-4-yl)-methanone;1-(2-Chloro-4-nitrophenyl)-4-[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]-piperazine;[4-(2-Chloro-4-nitrophenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)methanone;CS-681;Nucleozin >=98% (HPLC), powder;inhibit,Nucleozin,viral,Inhibitor,infection,Influenza Virus,nuclear,nucleoprotein,virus,replication,accumulation | CAS: | 341001-38-5 | MF: | C21H19ClN4O4 | MW: | 426.85 | EINECS: | | Product Categories: | | Mol File: | 341001-38-5.mol | |
| Methanone, [4-(2-chloro-4-nitrophenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)- Chemical Properties |
density | 1.371 | storage temp. | 2-8°C | solubility | DMSO: >15mg/mL | form | powder | color | yellow |
Hazard Codes | T | Risk Statements | 25 | Safety Statements | 45 | WGK Germany | 3 |
| Methanone, [4-(2-chloro-4-nitrophenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)- Usage And Synthesis |
| Methanone, [4-(2-chloro-4-nitrophenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)- Preparation Products And Raw materials |
|